cefixime has been researched along with Retrolental Fibroplasia in 1 studies
Cefixime: A third-generation cephalosporin antibiotic that is stable to hydrolysis by beta-lactamases.
cefixime : A third-generation cephalosporin antibiotic bearing vinyl and (2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetamido groups at positions 3 and 7, respectively, of the cephem skeleton. It is used in the treatment of gonorrhoea, tonsilitis, pharyngitis, bronchitis, and urinary tract infections.
Excerpt | Relevance | Reference |
---|---|---|
"Ocular examination revealed orbital cellulitis." | 1.72 | A tale of orbital cellulitis and retinopathy of prematurity in an infant: First case report. ( Gurnani, B; Kannusamy, V; Kaur, K; Yadalla, D, 2022) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Kaur, K | 1 |
Gurnani, B | 1 |
Kannusamy, V | 1 |
Yadalla, D | 1 |
1 other study available for cefixime and Retrolental Fibroplasia
Article | Year |
---|---|
A tale of orbital cellulitis and retinopathy of prematurity in an infant: First case report.
Topics: Cefixime; Child; Female; Gestational Age; Humans; Infant; Infant, Low Birth Weight; Infant, Newborn; | 2022 |